BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1487241)

  • 1. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS; King RA
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.
    Oetting WS; King RA
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):274-8. PubMed ID: 1292009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
    Oetting WS; Fryer JP; King RA
    Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
    Oetting WS; Mentink MM; Summers CG; Lewis RA; White JG; King RA
    Am J Hum Genet; 1991 Jul; 49(1):199-206. PubMed ID: 1905879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS; King RA
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
    Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosinase gene mutations causing oculocutaneous albinisms.
    Tomita Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
    Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
    Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.